EZH2 Homogeneous Assay Kit

Catalog #
52059
$3,100 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The EZH2 Homogenous Assay Kit is designed to measure activity of the EZH2 (enhancer of zeste homolog 2) complex (EZH2/EED/SUZ12/RbAp48/ AEBP) for screening and profiling purposes. The EZH2 Homogeneous Assay Kit comes in a convenient format 384-well AlphaLISA® format, with enough purified recombinant EZH2 complex, S-adenosylmethionine, primary antibody, substrate and buffers for 400 enzyme reactions.

The EZH2 Homogeneous Activity Assay Kit uses a highly specific antibody. In a first step, the methyltransferase is incubated with the substrate for one hour. This is followed by addition of the primary antibody and acceptor beads. Finally, the donor beads are added, and Alpha-counts are measured. The Alpha-counts are proportional to the EZH2 activity.

Synonyms
KTM6A, EZH2, PRC2, Enhancer Of Zeste Homolog 2, EZH, EZH-2
Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Materials Required But Not Supplied
  • AlphaLISA® Anti-Rabbit IgG Acceptor Beads, 5 mg/ml (Perkin Elmer #AL104C)
  • AlphaScreen® Nickel Donor Beads, 5 mg/ml (Perkin Elmer #AS101D)
  • Optiplate - 384 (Perkin Elmer #6007290)
  • AlphaScreen® microplate reader
Format

Catalog #

Name

Amount

Storage

51004

EZH2/EED/SUZ12/RbAp48/AEBP2, FLAG-Tag, His-Tag*

2 x 25 µg

-80°C

52120

20 μM S-adenosylmethionine

2 x 250 µl

-80°C

52140F

Primary Antibody 6

20 µl

-20°C

 79867

Histone Octamer Substrate

400 µl

-80°C

52170-A

4x HMT Assay Buffer 2A

3 ml

-20°C

 

4x Detection buffer 2

2 ml

-20°C

UniProt #
Q15910
Background

EZH2 (enhancer of zeste homolog 2) is a histone-lysine N-methyltransferase enzyme, that acts by adding methyl groups to the lysine 27 (K27) of histone H3, making it a silent chromatin. It is a functional unit of the larger complex PRC2 (polycomb repressive complex 2), which also includes EED, Suz12, AEBP2 (adipocyte enhancer-binding protein) and RbAp48 (histone-binding protein RBBP4). PRC2 is crucial for epigenetic regulation and is involved in stem cell differentiation and embryonic development. Abnormalities in PRC2 result in cancer since this complex also promotes double strand DNA repair. EZH2 is seen as an attractive target in cancer therapy, as its levels are elevated in multiple cancer types (example, breast, renal cancer, melanoma, and lymphoma). The development of inhibitors for EZH2 and PRC2 is a promising area of research for the treatment of cancer.

References
Dillon S.C., et al. 2005. Genome Biology 6:227.